# 5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme

> **NCT03291990** · EARLY_PHASE1 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 3 (actual)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **DRUG:** Temozolomide

## Key facts

- **NCT ID:** NCT03291990
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-18
- **Primary completion:** 2020-08-19
- **Final completion:** 2020-08-19
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2021-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03291990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03291990, "5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03291990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*